Serving To Educate Primary Care Clinicians On Metabolic Issues
Evidence Based Medicine Header 1
Medical Education Header 2
Peer-to-peer Exchange Header 3
Metabolic Diseases Header 4
News: Prescriber's Letter June 2015
Prescriber’s Letter addresses the drug therapy issues facing medical professionals. For example:

  • How do the new AACE Guidelines differ from the new ADA guidelines?
  • Do the meds started differ on initial A1C?
  • What is the target A1C?
For answers see our article: individualizing metformin add-ons in patients with type 2 diabetes

Login if you are a current subscriber to Prescriber's Letter.
Subscribe now to get instant access and the answers you need.

Additional information is available in our Detail-Document:

What's New in the Management of Hyperglycemia in Type 2 Diabetes?

For the most recent full article AND to access all of the benefits of Prescriber's Letter subscribe to an option below:

Prescriber's Letter offers PCMG Members a 10% discount at two subscription levels:

The Gold Subscription is $129 and includes CME

The Platinum Subscription is $189 and provides enhanced CME and Live Webinar access 

Enter Discount Code PCMG15 when ordering either subscription HERE